Nicholas J Leeper MD
Adult Congenital Heart Disease
Assistant Professor, Surgery - Vascular Surgery, Stanford University
Join to View Full Profile
300 Pasteur DrPalo Alto, CA 94304
Phone+1 650-723-4000
Are you Dr. Leeper?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Nicholas Leeper, MD is a cardiologist in Palo Alto, California. He is currently licensed to practice medicine in California. He is an Assistant Professor at Stanford University.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Cardiovascular Disease, 2005 - 2009
University of California (San Francisco)Residency, Internal Medicine, 2003 - 2006
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2003
Certifications & Licensure
CA State Medical License 2005 - 2026
American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- Temporal Effects of Plozasiran on Lipids and Lipoproteins in Persistent Chylomicronemia.Gerald F Watts, Robert A Hegele, Robert S Rosenson, Ira J Goldberg, Antonio Gallo
Circulation. 2025-03-11 - Vascular smooth muscle cell plasticity in the tumor microenvironment.Caitlin F Bell, Richard A Baylis, Nicolas G Lopez, Wei Feng Ma, Hua Gao
Cancer Communications. 2025-02-01 - 14 citationsPlozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk.Gerald F Watts, Robert S Rosenson, Robert A Hegele, Ira J Goldberg, Antonio Gallo
The New England Journal of Medicine. 2025-01-09
Press Mentions
Remembering Joel S. Bennett, and MoreAugust 2nd, 2021- This Medication Can Raise Heart Attack Risk up to 21 Percent, Study ShowsJune 23rd, 2021
- Damon Runyon Cancer Research Foundation Announces 2021 Physician-Scientist AwardeesJune 3rd, 2021
- Join now to see all
Grant Support
- Clonal expansion, resistance to efferocytosis and innate immunity in atherosclerosisSTANFORD UNIVERSITY2019–2025
- T32 Training Program in Mechanisms and Innovation in Vascular DiseaseSTANFORD UNIVERSITY2010–2025
